Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 4.640
+0.530 (12.90%)
At close: Dec 24, 2025
Artrya Market Cap
Artrya has a market cap or net worth of 733.51 million as of December 26, 2025. Its market cap has increased by 1,471.05% in one year.
Market Cap
733.51M
Enterprise Value
722.80M
Revenue
28.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.64
Market Cap Chart
Since November 26, 2021, Artrya's market cap has increased from 119.12M to 733.51M, an increase of 515.77%. That is a compound annual growth rate of 56.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 733.51M | 1,412.88% |
| Dec 31, 2024 | 48.48M | 156.86% |
| Dec 29, 2023 | 18.88M | -39.81% |
| Dec 30, 2022 | 31.36M | -69.23% |
| Dec 31, 2021 | 101.94M | -14.43% |
| Nov 26, 2021 | 119.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 82.72B |
| Pro Medicus | 23.58B |
| Cochlear | 17.13B |
| Sonic Healthcare | 11.15B |
| Ramsay Health Care | 8.09B |
| Ansell | 5.05B |
| Telix Pharmaceuticals | 4.03B |
| Mesoblast | 3.72B |